Reimagining the Life Sciences value chain with AI and analytics

services-bg

Explore how advanced analytics helps unlock profitable growth, enhance patient outcomes, and accelerate innovation

services-bg

Deliver on-demand Life Sciences capabilities with analytics

With increasing pressure to accelerate digital capabilities, identify and target the right Healthcare Professionals (HCPs), partner with rare-disease patients and their caregivers, improve overall patient outcomes, and navigate complex regulatory environments, life sciences companies are adopting scalable and adaptable solutions. This is where extensive expertise in AI/ML, data and ML engineering, MLOps, and deep domain knowledge can empower organizations with data-driven capabilities and transformative solutions.

At Tiger Analytics, we understand the unique complexities and opportunities within the life sciences industry and offer expertise in leveraging AI/ML and data-driven strategies to drive positive outcomes. Our data-driven strategies and intelligent frameworks help life science players like you better understand HCPs’ needs, support patient journeys to improve patient outcomes, drive innovation, and optimize overall sales and marketing efforts.

What we do

01

Product launch and life-cycle management

Our solutions help you improve the success of drug launches and lifecycle management strategies, equipping you with insights on markets, competitors, and the target patient population while optimizing your resources and managing risks.

02

Personalized patient engagement

Our solutions help you identify patients who are most likely to benefit from your products, increase patient engagement, track adherence to treatment plans, and improve overall patient outcomes.

03

Omnichannel HCP engagement

Our solutions help you understand HCP preferences and behaviors across channels to execute optimized omnichannel campaigns that personalize, engaging and drive targeted outcomes.

04

Sales and marketing effectiveness

Our solutions help improve the efficiency and effectiveness of your sales and marketing spend by identifying trends, recommending next best actions, optimizing spend and tracking performance.

Customer stories

AI-powered early detection of rare diseases for global pharma
AI-powered early detection of rare diseases for global pharma
Tiger Analytics' AI/ML pinpointed rare disease patients early, enhancing treatments for a global pharma.
Readshp-arrow-topright-large
Global pharma’s engagement solution delivers 75% HCP response boost
Global pharma’s engagement solution delivers 75% HCP response boost
Tiger Analytics’ strategy for a global pharma enhanced HCP engagement and amplified its market reach and efficiency.
Readshp-arrow-topright-large
ML model to understand the root cause of therapy discontinuation
ML model to understand the root cause of therapy discontinuation
Tiger Analytics helped a Fortune 500 pharma company understand the drivers behind therapy discontinuation at the patient level and in designing targeted programs for improving patient adherence.
Readshp-arrow-topright-large
FAQs
How do you choose an AI and analytics partner for life sciences?

Choosing the right partner requires balancing life sciences domain expertise with end-to-end technical capabilities. A strong partner will bring proven experience across healthcare professional (HCP) engagement, rare disease detection, and regulatory compliance, while also having technical mastery in AI/ML engineering, data modernization, and MLOps. Organizations should prioritize partners with pre-built accelerators and a track record of delivering measurable commercial and clinical outcomes.

What AI and analytics services does Tiger Analytics offer for life sciences companies?

Tiger Analytics delivers a comprehensive suite of data, AI, and analytics services tailored to life sciences organizations. Our solutions span product launch and lifecycle management, as well as personalized patient engagement tools designed for early disease detection and adherence tracking. We optimize omnichannel HCP engagement through behavioral mapping and maximize commercial return using advanced sales and marketing effectiveness models.

How are GenerativeAI and Agentic AI used in life sciences?

Generative AI and Agentic AI expand commercial and operational capabilities across the life sciences value chain. GenAI automates scientific documentation, creates personalized content for HCP campaigns, and allows teams to query complex enterprise data using natural language. Agentic AI operates to orchestrate multi-step workflows, such as executing action-based patient adherence interventions and managing real-time compliance checks.

How do life sciences enterprises build commercial data products?

Life sciences enterprises build commercial data products by transforming raw enterprise and third-party data into scalable, reusable assets. The process begins with modernizing data foundations by unifying EHR, claims, and interaction data into centralized cloud pipelines. Companies then build standardized ML products, such as campaign optimization engines and patient journey trackers, and integrate them into field applications and business intelligence dashboards via MLOps for real-time decision-making.

How can life sciences companies scale AI and analytics programs?

Scaling AI beyond isolated pilot projects requires establishing strategic roadmaps that align platform architecture with business goals. Organizations accelerate rollout by leveraging pre-built frameworks, open IP, and reusable code libraries to democratize analytics across teams. Industrializing MLOps ensures model deployment and continuous monitoring. Maintenance is fully automated across global markets.

How can life sciences enterprises govern data and AI for regulatory compliance?

Data and AI governance must be embedded directly into the engineering and development lifecycle to maintain regulatory compliance across Life Science enterprises. This involves implementing strict access controls, encryption, and consent tracking to adhere to global privacy standards like HIPAA and GDPR. Organizations must utilize explainable AI models to ensure clinical and commercial algorithms remain auditable, while leveraging automated MLOps pipelines to monitor for data drift and bias.

Copyright © 2026 Tiger Analytics | All Rights Reserved